Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Summary: Acetylation of histone H3 at lysine 27 is a well-defined marker of enhancer activity. However, the functional impact of this modification at enhancers is poorly understood. Here, we use a chemical genetics approach to acutely block the function of the cAMP response element binding protein (...
Main Authors: | Ryan Raisner, Samir Kharbanda, Lingyan Jin, Edwin Jeng, Emily Chan, Mark Merchant, Peter M. Haverty, Russell Bainer, Tommy Cheung, David Arnott, E. Megan Flynn, F. Anthony Romero, Steven Magnuson, Karen E. Gascoigne |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718311446 |
Similar Items
-
Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation
by: Denise E. de Almeida Nagata, et al.
Published: (2019-04-01) -
Epigenetic mechanisms to propagate histone acetylation by p300/CBP
by: Masaki Kikuchi, et al.
Published: (2023-07-01) -
CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation
by: Olzscha, H, et al.
Published: (2016) -
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
by: Popp, T, et al.
Published: (2016) -
CBP/p300 bromodomain: new promising epigenetic target
by: Xiang Qiuping, et al.
Published: (2022-01-01)